Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation
Human Gene Therapy · 2024-04 · 35 (7-8) · 284-297
DOI: 10.1089/hum.2023.193 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Gene Therapy, online erschienen am 16.04.2024. Verfasst von Michelle Mendiola Pla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Organ Transplantation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Ex vivo machine perfusion (EVMP) is rapidly growing in utility during solid organ transplantation. This form of organ preservation is transforming how organs are allocated and expanding the definition of what is considered a suitable organ for transplantation in comparison with traditional static cold storage. All major organs (heart, lung, liver, kidney) have been influenced by this advanced method of organ preservation. This technology also serves as an unprecedented platform for effective administration of advanced therapeutics, including gene therapies, during organ transplantation to optimize and recondition organs ex vivo in an isolated manner. Applying gene therapy interventions through EVMP introduces different considerations and challenges that are unique from gene therapies designed for systemic administration. Considerations involving vector (choice, dose, toxicity), perfusate composition, and perfusion circuit components should be evaluated when developing a gene therapy to administer in this setting. This review explores these aspects and discusses clinical applications in transplantation where gene therapy interventions can be developed relevant to heart, lung, liver, and kidney donor grafts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
ORCID-Profile: Michelle Mendiola Pla
Förderung
- NHLBI NIH HHS
Zitieren
APA
Mendiola Pla, M., & Bowles, D. E. (2024). Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation. Human Gene Therapy, 35(7-8), 284-297. https://doi.org/10.1089/hum.2023.193
Vancouver
Mendiola Pla M, Bowles DE. Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation. Human Gene Therapy. 2024;35(7-8):284-297. doi:10.1089/hum.2023.193
BibTeX
@article{MendiolaPla2024,
author = {Mendiola Pla, Michelle and Bowles, Dawn E},
title = {Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation},
journal = {Human Gene Therapy},
year = {2024},
volume = {35},
number = {7-8},
pages = {284--297},
doi = {10.1089/hum.2023.193}
}
EUVIMED